AbbVie Claims Rinvoq Superiority To Dupixent In AD

 
• By Joseph Haas
Head to head battle
Rinvoq shows efficacy edge vs. Dupixent in head-to-head trial • Source: Alamy

More from Clinical Trials

More from R&D